Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor

BACKGROUND: Though pathologic evidence for non-small cell lung cancer (NSCLC) is preferred, many patients do not receive a biopsy prior to treatment with stereotactic body radiation therapy (SBRT). This study seeks to analyze the overall survival (OS), local control, and toxicity rates for such pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalchuk, Roman O., Waters, Michael R., Baliga, Sujith, Richardson, K. Martin, Spencer, Kelly M., Larner, James M., Kersh, Charles R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653131/
https://www.ncbi.nlm.nih.gov/pubmed/33209608
http://dx.doi.org/10.21037/tlcr-20-469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653131/
https://www.ncbi.nlm.nih.gov/pubmed/33209608
http://dx.doi.org/10.21037/tlcr-20-469

Ejemplares similares